Francie Barron, Phd Email & Phone Number

Provide comprehensive business development and commercial strategy consulting for biotech companies from start-up to growth stage. Develop product and customer pipelines, creating go-to-market strategies that drive revenue growth. Conduct in-depth market analysis and competitive landscape assessments to inform strategic decision making. Collaborate with cross-functional internal teams to align R&D, commercial, and corporate objectives.

Somersham, Cambridgeshire, Gb

Partner with the Chief Commercial Officer to develop and execute commercial strategy. ★ Coordinate with the product manager to define the product vision, build a pipeline, evaluate markets, and align product and corporate goals, incorporating voice of the customer (VOC). ★ Study critical challenges in multiple verticals – environment, agriculture, diagnostics, health/wellness, and veterinary – to pitch products’ problem-solving efficacy to potential partners. KEY ACHIEVEMENTS★ Facilitated the commercial integration of Cardea and Paragraf biosensor processes to expedite entry into the biosensor market; analyzed leads and processes, reconciled disparate practices, and established new processes.★ Closed a material transfer agreement (MTA) with a top 10 diagnostic company within the first two months.★ Springboarded off the merger announcement to reinvigorate an existing lead and pitched product capabilities to business leaders and scientists.

San Diego, California, Us

Collaborated with the Chief Business Officer to devise and implement a commercial strategy to engage academic and industry partners in multiple market verticals. ★ Synthesized partners’ needs and determined how the platform solution could solve problems and create new customer-facing products. ★ Roadmapped research and development, clinical, and regulatory pathways to market. ★ Guided marketing in creating, branding, and refining inbound and outbound collateral, including investor/partner newsletter and targeted pitch decks. ★ Presented at conferences and managed tradeshow booths to attract commercial and academic partners. Contributed to multiple peer-reviewed publications. ★ Supervised two direct reports (partnerships and alliance management). KEY ACHIEVEMENTS★ Negotiated and solidified 13 partner contracts for a $MM total.★ Closed a deal with the Bill & Melinda Gates Foundation to develop an electronic nose for disease detection; solidified the agreement in less than three months. ★ Solidified Cooperative Research and Development Agreements (CRADA), academic and commercial licenses, Collaborative Research Agreements (CRA), Confidential Disclosure Agreements (CDA), Letters of Intent (LOI), and Memorandums of Understanding (MOU) with various partners, including startups, healthcare and biotechnology academic groups, and Fortune 100/500 companies. ★ Included commercial licensing terms in CRAs to ensure continuity upon successful feasibility studies.★ Created templates for multiple agreement and partner types.★ Leveraged the commercial vision to build a partner pipeline and manage it from lead through signed contract. Set up revenue-generating initiatives; quickly demonstrated the new model’s success to the board/investors.★ Devised processes that enabled rapid qualification of potential partners and identification of needs that matched BPU functionality. Evaluated 500+ companies.

Contributed knowledge of biology and regulatory affairs to product development, functionality, and go-to-market efforts. ★ Partnered with technical leadership to build customer pipeline, make product decisions, carve out a niche in the market, develop marketing, and facilitate customer relations. ★ Focused on products for infectious disease, therapeutic drug monitoring (TDM), and life science tools. Managed a team of research associates, field application scientists, senior scientists, directors, and support staff. ★ Reported directly to the CTO.KEY ACHIEVEMENTS★ Spearheaded the development and launch of the biophysical life science tool Agile R100, providing drug discovery and diagnostic academic/pharmaceutical researchers with a reasonably priced, at-the-bench solution to manage biophysical data and calculations.★ Defined market pain points and collaborated with marketing and R&D on product development.Developed the investor pitch and regulatory affairs strategy to facilitate market clearance★ Managed FDA pre-submission process and meetings and assisted in preparing GMP/GLP-compliant processes to set the company up for future ISO 9001 and 13485 certifications. ★ Roadmapped experiments to generate data and use cases for marketing collateral and peer-reviewed publications to build credibility among target audiences. ★ Partnered with the Vice President of Marketing in creating white papers, marketing collateral, user manuals, kit structure, and use cases. ★ Sold more than 20 units in two years; many are still active today, including the first unit ever purchased.★ Wrote the organization’s first successful grant, a DARPA grant to fund the creation of a bedside antibiotic therapeutic drug monitoring system for the US Army.★ Maintained a CRADA that enabled Nanomedical Diagnostics to utilize the CDC’s novel antibodies.

Provided quality control and quality assurance (QC/QA) review for regulatory and clinical documents.★ Assessed investigator’s brochures (IB), informed consent forms (ICF), clinical protocols, clinical study reports (CSR), and nonclinical study reports. ★ Focused on endocrine, oncology, and vaccines.KEY ACHIEVEMENTS★ Contributed to the “de-MS-tifying Word” column published in Postscripts, the monthly newsletter for the Pacific Southwest Chapter of the American Medical Writers Association.

Monitored clinical trial sites across the US, focusing on cardiology, oncology, and infectious disease. ★ Authored Investigational New Drug (IND) application amendments, clinical/nonclinical study reports, and serious adverse event (SAE) reports for FDA and NIH. ★ Executed clinical trial data locks, including query creation, resolution, and close-out. ★ Reviewed grant proposals to public and private funding sources. Led an internal GCP audit.

Palo Alto, Ca, Us

Used induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) to model atrial fibrillation and develop in vitro novel drug testing assays.★ Designed protocols and experiments for collaborative projects that used iPSC-CMs or iPSC-derived endothelial cells to model disease states, test drugs, or to understand developmental signaling pathways.

Studied novel proteins related to chromosome dynamics during division and cytokinesis.★ Set up and maintained a new lab.★ Hired and trained laboratory assistants, procured resources, and managed finances and regulatory compliance.★ Maintained and created transgenic worm lines.★ Created antibodies for C. elegans novel proteins discovered in the lab.★ Co-designed experiments with graduate students and postdoctoral researchers.★ Contributed to the publication of 5 papers.

Doctor Of Philosophy (Ph.D.), Cell Biology, Stem Cells And Development

Bachelor'S Degree, Biochemistry/Cell Biology

Semester Abroad Program